Evidence map›Paper›PMID 38650465›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences2024

Rates and Predictors of Rapid Eye Movement Sleep Behavior Disorder Symptoms Among Post-9/11 Veterans.

Melissa B Jones, Juliann Tea, Matthew Meyers, Ruosha Li, Audri Villalon, Ritwick Agrawal, Ricardo E Jorge

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Melissa B JonesMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Juliann TeaMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Matthew MeyersMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Ruosha LiMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Audri VillalonMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Ritwick AgrawalMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Ricardo E JorgeMental Health Care Line (Jones, Jorge), Research Care Line (Jones, Villalon), and Medical Care Line (Agrawal), Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston; Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences (Jones, Villalon, Jorge), and Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (Agrawal), Baylor College of Medicine, Houston; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tea); Division of Clinical Pharmacology, Department of Medicine, and Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Meyers); Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center, Houston (Li).
Michael E. DeBakey VA Medical Center · US

Funding

Clinical Pharmacology Training ProgramT32GM066691 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Matthew Michael Ippolito · 2003 to 2026
$6.4M
Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS)I50RX003001 · VA · VA BOSTON HEALTH CARE SYSTEM · PI Ricardo E. Jorge, WILLIAM P MILBERG · 2018 to 2026
–
Pimavanserin for Insomnia in Veterans with Post-traumatic Stress DisorderIK2CX002363 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI Melissa Beth Jones · 2023 to 2026
–
CSRD VA IK2 CX002363NIGMS NIH HHS T32 GM066691RRD VA I50 RX003001
6 · The paper itself

Abstract

objectivePosttraumatic stress disorder (PTSD) and traumatic brain injury (TBI), which are prevalent conditions among post-9/11 veterans, increase risks of rapid eye movement (REM) sleep behavior disorder (RBD) and degenerative synucleinopathy. Rates and predictors of RBD symptoms were investigated by screening post-9/11 veterans for RBD with a validated questionnaire.

methodsIn this cross-sectional analysis, consecutive patients in the Houston Translational Research Center for TBI and Stress Disorders (TRACTS) were screened with the English translation of the RBD Questionnaire-Hong Kong (RBDQ-HK). In addition to data from the standard TRACTS battery, systematic chart review was used to identify known sleep disorders mimicking or manifesting RBD.

resultsOf the 119 patients with available RBDQ-HK scores, 71 (60%) and 65 (55%) screened positive for RBD, when a total score ≥21 and a factor 2 score ≥8 were used as cutoff scores, respectively. Univariable analyses with both cutoffs showed consistent associations between a positive RBDQ-HK screen and global sleep quality, number of TBI exposures, and PTSD severity. Multivariable logistic regression with total score ≥21 as a cutoff indicated that PTSD severity (odds ratio=1.06, 95% CI=1.02-1.10) and number of TBIs (odds ratio=1.63, 95% CI=1.16-2.41) were independent predictors of a positive screen, whereas global sleep quality was no longer significant. Multivariable logistic regression with factor 2 score ≥8 as a cutoff showed similar results.

conclusionsInterdisciplinary parasomnia assessment, further validation of RBD screens, and standardized reporting of REM sleep without atonia could provide necessary information on the pathophysiological relationships linking PTSD, TBI, RBD symptoms, and ultimately synucleinopathy risk among post-9/11 veterans.

Indexed as

REM Sleep Behavior DisorderStress Disorders, Post-TraumaticVeteransAdultAgedBrain Injuries, TraumaticCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesParasomniasPosttraumatic Stress DisorderRapid Eye Movement SleepREM Sleep Behavior DisorderTraumatic Brain InjuryVeterans

Identifiers

PMID38650465
PMCPMC11479852
OpenAlexW4395048056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.